Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.

Else, Monica

Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma. [electronic resource] - British journal of haematology Nov 2012 - 322-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1365-2141

10.1111/bjh.12036 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Disease Progression
Female
Humans
Lymphoma, B-Cell, Marginal Zone--drug therapy
Male
Middle Aged
Rituximab
Splenic Neoplasms--drug therapy
Treatment Outcome